These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12794086)

  • 1. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
    Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
    J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
    Xiao Z; Latek R; Lodish HF
    Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
    Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
    J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nuclear export signal in Smad1 is essential for its signaling activity.
    Xiao Z; Brownawell AM; Macara IG; Lodish HF
    J Biol Chem; 2003 Sep; 278(36):34245-52. PubMed ID: 12821673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
    Stroschein SL; Bonni S; Wrana JL; Luo K
    Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.
    Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH
    Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
    De Bosscher K; Hill CS; Nicolás FJ
    Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
    Maurice D; Pierreux CE; Howell M; Wilentz RE; Owen MJ; Hill CS
    J Biol Chem; 2001 Nov; 276(46):43175-81. PubMed ID: 11553622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of mono-ubiquitinated Smad4 in the formation of Smad transcriptional complexes.
    Wang B; Suzuki H; Kato M
    Biochem Biophys Res Commun; 2008 Nov; 376(2):288-92. PubMed ID: 18783722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.
    Wan M; Tang Y; Tytler EM; Lu C; Jin B; Vickers SM; Yang L; Shi X; Cao X
    J Biol Chem; 2004 Apr; 279(15):14484-7. PubMed ID: 14988407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
    Pierreux CE; Nicolás FJ; Hill CS
    Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
    Imoto S; Sugiyama K; Sekine Y; Matsuda T
    FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.